ADMA Biologics's total assets for Q3 2024 were $390.62M, an increase of 3.78% from the previous quarter. ADMA total liabilities were $158.73M for the fiscal quarter, a -15.63% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.